pyrimidine has been researched along with Urinary Bladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, Y; Echizen, Y; Hirano, M; Hisamichi, H; Iikubo, K; Iwai, Y; Kameda, M; Kawamoto, Y; Kikuchi, S; Kondoh, Y; Kuriwaki, I; Moritomo, H; Nakazawa, T; Noda, A; Tateishi, Y; Terasaka, T; Tomiyama, H | 1 |
| Allen, MD; Avril, N; Beltran, L; Bomalaski, JS; Chelala, C; Chmielewska-Kassassir, M; Crook, T; Cutts, R; Delage, B; Foster, J; Frezza, C; Ghazaly, E; Hudson, C; Jackson, RC; Jones, LJ; Lattanzio, L; Lemoine, NR; Leyton, J; Li, CF; Lo Nigro, C; Lu, YJ; Luong, P; Mather, S; Neal, D; Roylance, R; Sosabowski, J; Syed, N; Szlosarek, PW; Tomlinson, I; Warren, AY; Whitaker, HC; Wu, BW; Yuan, M | 1 |
2 other study(ies) available for pyrimidine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Dynamics Simulation; Molecular Structure; Neoplasms, Experimental; NIH 3T3 Cells; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 3; Solubility; Structure-Activity Relationship; Urinary Bladder Neoplasms | 2021 |
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.
Topics: Animals; Antimetabolites, Antineoplastic; Argininosuccinate Synthase; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; DNA Methylation; Drug Synergism; Female; Glutamates; Guanine; Humans; Hydrolases; Immunohistochemistry; Mice; Neoplasm Invasiveness; Pemetrexed; Polyethylene Glycols; Positron-Emission Tomography; Prognosis; Pyrimidines; Urinary Bladder Neoplasms; X-Ray Microtomography | 2014 |